Reclassifying Cannabis In 2026 Means Big Changes For The Workplace
Dr. Dave Rabin, MD, PhD, executive director of The Board of Medicine, shares his perspective on developing guidelines for medicines like cannabis, psilocybin and MDMA.
Read the full article here
Source: Forbes
Posted on: December 23, 2025